Harpoon Therapeutics Captures $45M For Cancer Therapeutics
South San Francisco-based biotech startup Harpoon Therapeutics, which is developing T-cell recruiting biologic therapies for the treatment of cancer, has raised $45M in a Series B funding round. The funding was led by Arix Bioscience and New Leaf Venture Partners, and also included Arix Bioscience, New Leaf Venture Partners, Taiho Ventures, and MPM Capital. Mark Chin of Arix and Ron Hunt of New Leaf join the company's board, with Taiho's Sakae Asunuma joining as an observer.
posted on Friday, May 26, 2017 (Link to more information)
Related companies:
Harpoon Medical, Inc.
Related stories:
> Merck Buys Sirna Therapeutics
> Jennerex Raises $8.3M
> Iconic Therapeutics Adds $10M To Series C
> Iconic Therapeutics Finds $20M
> PEAR Therapeutics Gets $50M For Treating Substance Abuse With Software
silicontap.com Home